Bioneutra Global Stock Probability of Future Pink Sheet Price Finishing Over 0.067
| BGACF Stock | USD 0.07 0.00 0.00% |
BioNeutra |
BioNeutra Global Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of BioNeutra Global for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for BioNeutra Global can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| BioNeutra Global generated a negative expected return over the last 90 days | |
| BioNeutra Global has some characteristics of a very speculative penny stock | |
| BioNeutra Global has high likelihood to experience some financial distress in the next 2 years | |
| BioNeutra Global has accumulated 6.34 M in total debt. BioNeutra Global has a current ratio of 0.68, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist BioNeutra Global until it has trouble settling it off, either with new capital or with free cash flow. So, BioNeutra Global's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like BioNeutra Global sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for BioNeutra to invest in growth at high rates of return. When we think about BioNeutra Global's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 15.4 M. Net Loss for the year was (2.83 M) with profit before overhead, payroll, taxes, and interest of 2.89 M. | |
| About 37.0% of the company shares are held by company insiders |
BioNeutra Global Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of BioNeutra Pink Sheet often depends not only on the future outlook of the current and potential BioNeutra Global's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. BioNeutra Global's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 46.4 M |
BioNeutra Global Technical Analysis
BioNeutra Global's future price can be derived by breaking down and analyzing its technical indicators over time. BioNeutra Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of BioNeutra Global. In general, you should focus on analyzing BioNeutra Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
BioNeutra Global Predictive Forecast Models
BioNeutra Global's time-series forecasting models is one of many BioNeutra Global's pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary BioNeutra Global's historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about BioNeutra Global
Checking the ongoing alerts about BioNeutra Global for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for BioNeutra Global help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| BioNeutra Global generated a negative expected return over the last 90 days | |
| BioNeutra Global has some characteristics of a very speculative penny stock | |
| BioNeutra Global has high likelihood to experience some financial distress in the next 2 years | |
| BioNeutra Global has accumulated 6.34 M in total debt. BioNeutra Global has a current ratio of 0.68, indicating that it has a negative working capital and may not be able to pay financial obligations in time and when they become due. Debt can assist BioNeutra Global until it has trouble settling it off, either with new capital or with free cash flow. So, BioNeutra Global's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like BioNeutra Global sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for BioNeutra to invest in growth at high rates of return. When we think about BioNeutra Global's use of debt, we should always consider it together with cash and equity. | |
| The entity reported the revenue of 15.4 M. Net Loss for the year was (2.83 M) with profit before overhead, payroll, taxes, and interest of 2.89 M. | |
| About 37.0% of the company shares are held by company insiders |
Other Information on Investing in BioNeutra Pink Sheet
BioNeutra Global financial ratios help investors to determine whether BioNeutra Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioNeutra with respect to the benefits of owning BioNeutra Global security.